Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Cytek Biosciences (CTKB) Receivables Refunds (2020 - 2021)

Cytek Biosciences' Receivables Refunds history spans 2 years, with the latest figure at $1.4 million for Q3 2021.

  • For Q3 2021, Receivables Refunds changed N/A year-over-year to $1.4 million; the TTM value through Sep 2021 reached $1.4 million, changed N/A, while the annual FY2020 figure was $1.1 million, N/A changed from the prior year.
  • Receivables Refunds reached $1.4 million in Q3 2021 per CTKB's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $1.4 million in Q2 2021 to a low of $1.1 million in Q4 2020.